The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease.
about
Hepatitis C Virus Infection Induces Autophagy as a Prosurvival Mechanism to Alleviate Hepatic ER-Stress ResponseEndoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseasesPathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal CellsMouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease.Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH)Decreasing mitochondrial fission alleviates hepatic steatosis in a murine model of nonalcoholic fatty liver diseaseBiomarkers of NAFLD progression: a lipidomics approach to an epidemic.Loss of ULK1 increases RPS6KB1-NCOR1 repression of NR1H/LXR-mediated Scd1 transcription and augments lipotoxicity in hepatic cellsIL-1β-induced modulation of gene expression profile in human dermal fibroblasts: the effects of Thai herbal Sahatsatara formula, piperine and gallic acid possessing antioxidant properties.Undernourishment in utero Primes Hepatic Steatosis in Adult Mice Offspring on an Obesogenic Diet; Involvement of Endoplasmic Reticulum Stress.Polyphenol-Rich Fraction of Ecklonia cava Improves Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice.Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet.Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease.Impact of high cholesterol and endoplasmic reticulum stress on metabolic diseases: An updated mini-review.Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD.The role of fibroblast growth factor 21 in the pathogenesis of liver disease: a novel predictor and therapeutic target.Early to Phase II drugs currently under investigation for the treatment of liver fibrosis.Immunoregulation by lipids during the development of non-alcoholic steatohepatitis.Interactions of Hepatitis B Virus Infection with Nonalcoholic Fatty Liver Disease: Possible Mechanisms and Clinical Impact.Caring for children with NAFLD and navigating their care into adulthood.Lipotoxicity pathways intersect in hepatocytes: Endoplasmic reticulum stress, c-Jun N-terminal kinase-1, and death receptors.Undernourishment in utero and hepatic steatosis in later life: A potential issue in Japanese people.Development of gene polymorphisms in meditators of nonalcoholic fatty liver disease.Alcoholic steatohepatitis (ASH) causes more UPR-ER stress than non-alcoholic steatohepatitis (NASH).Dysregulated expression of proteins associated with ER stress, autophagy and apoptosis in tissues from nonalcoholic fatty liver diseasePunicalagin attenuates palmitate-induced lipotoxicity in HepG2 cells by activating the Keap1-Nrf2 antioxidant defense system.Mitogen-Activated Protein Kinase Regulation in Hepatic Metabolism.The constitutive lipid droplet protein PLIN2 regulates autophagy in liver.To die or not to die: death signaling in nonalcoholic fatty liver disease.Role of X-Box Binding Protein-1 in Fructose-Induced Lipogenesis in HepG2 CellsA nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis
P2860
Q26745984-D4949291-A769-4E24-8FF5-6ED728BCAA6EQ27027733-09A8DB6A-B942-4F35-BED8-A919D43B9589Q28071596-8FEBB57D-BB5D-424E-A7EB-84372C325F7AQ30375036-3BFB1F1E-184F-420D-ABDE-2767C1FCCBE7Q33755566-2D6D1BD7-F9C2-46F4-9594-5D3A1BF2D148Q34200914-38ED7BC6-E746-435A-A53D-F06F4AF71961Q35120968-EA6960FE-9EA8-43AE-B66C-E9CD1DE7D803Q36193081-488E3309-B59A-4132-B851-83F5EC363711Q36244747-BD023E4A-5531-4FE7-8A1C-B8692CCFEFA5Q36298151-CB64F232-AE4F-48C5-875B-684CC23ED201Q36329720-273BC4A1-59B9-42A5-A47B-14520A7A9339Q36382065-3159C751-F007-4E27-8D6A-85F4EBA8C122Q37062751-88AC9953-2204-46B1-9B64-5A367083AB15Q37710429-321DF1D2-1C5F-4962-B5B7-6865551A159EQ37726154-B610C931-AB45-46A5-ADC8-438BB9893D36Q38235454-4251A7D2-D850-452D-BB2F-3FB2E74D5E33Q38303313-351DCDF1-5D98-459D-8F47-398C2132106FQ38365029-FF92491C-9236-4E2F-9EAA-E68E60A4AB34Q38538187-24C7495B-AD62-4B1D-95A5-249441DBB795Q38577570-77D5B2C1-8616-4F0A-BBD5-9DA74A69FBC4Q38759104-A04EDC91-64AB-41DB-9614-1F7CC96AB1F6Q38793946-91210822-688E-4585-8EDF-7A8B6BD6E41BQ41115099-54D3A2E0-49B1-4F75-8A78-72A81725B5EBQ41641615-CCB0D604-4C5D-4562-97DB-EA42F1C9C203Q42362670-96D6AAD9-4460-4099-ACE7-B5A13FC91E26Q46577839-315B6C99-FB1B-4DAC-BB1C-84E0E2DCF142Q47413881-27736340-A729-4C63-905D-E8C3A5442910Q50977546-5260E68D-4711-4A9A-A965-728EF3366A38Q54119547-23241745-D780-42C8-B1D3-54F30A2B87A0Q56979449-C1012828-8E5F-4BD0-A9E9-47D616BBFF1FQ58697388-66844450-334E-4467-9093-BD13FE56DB44
P2860
The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The adaptive endoplasmic retic ...... alcoholic fatty liver disease.
@en
The adaptive endoplasmic retic ...... alcoholic fatty liver disease.
@nl
type
label
The adaptive endoplasmic retic ...... alcoholic fatty liver disease.
@en
The adaptive endoplasmic retic ...... alcoholic fatty liver disease.
@nl
prefLabel
The adaptive endoplasmic retic ...... alcoholic fatty liver disease.
@en
The adaptive endoplasmic retic ...... alcoholic fatty liver disease.
@nl
P2093
P2860
P356
P1476
The adaptive endoplasmic retic ...... alcoholic fatty liver disease.
@en
P2093
April D Lake
Brieanna Flores-Keown
Nathan J Cherrington
Rhiannon N Hardwick
Walter T Klimecki
P2860
P356
10.1093/TOXSCI/KFT230
P577
2013-10-04T00:00:00Z